- Synthesis and Screening of Substituted 1,4-Naphthoquinones (NPQs) as Antifilarial Agents
[作者:Mathew, N; Karunan, T; Srinivasan, L; Muthuswamy, K,期刊:Drug Development Research, 页码:188-196 , 文章类型: Article,,卷期:2010年71-3]
- Eleven amino-substituted 1,4-naphthoquinones were synthesized via the reaction of 1,4-naphthoquinone with different primary and secondary mono- and diamines in the presence of dichloromethane ethanol (1:2) solvent at roo...
- New Biological Investigations on 3-Bromophenyl 6-Acetoxymethyl-2-oxo-2H-1-Benzopyran-3-Carboxylate as Anti-angiogenic Agent
[作者:Hemmer, M; Kempen, I; de Tullio, P; Frankenne, F; Lambert, V; Blacher, S; Bueb, JL; Foidart, JM; Noel, A; Tschirhart, E; Pirotte, B,期刊:Drug Development Research, 页码:209-218 , 文章类型: Article,,卷期:2010年71-3]
- The development of blood vessels inside tumors is required to provide the nutrients and oxygen needed for tumor growth and to allow the spread of cancer cells at a distance to form metastasis. Angiogenesis is also implic...
- Artesunate Plus Amodiaquine Combination Therapy - Reviewing the Evidence (vol 71, pg 33, 2010)
[作者:Adjei, GO; Kudzi, W; Dodoo, A; Kurtzhals, JAL,期刊:Drug Development Research, 页码:219-219 , 文章类型: Correction,,卷期:2010年71-3]
-
- Gaining Time: Early Treatment of Severe Pediatric Malaria in Tanzania (vol 71, pg 92, 2010)
[作者:Gomes, MF; Warsame, M; Nasemba, N; Singlovic, J; Kapinga, A; Mwankuyse, S; Mduma, S; Msabaha, MH; Mulokosi, F; Shishira, J; Kitua, A; Mrango, Z,期刊:Drug Development Research, 页码:220-220 , 文章类型: Correction,,卷期:2010年71-3]
-
- Targeting the Pentose Phosphate Pathway in Syndrome X-Related Cardiovascular Complications
[作者:Gupte, SA,期刊:Drug Development Research, 页码:161-167 , 文章类型: Review,,卷期:2010年71-3]
- Syndrome X is a combination or co-occurrence of several known cardiovascular risk factors (including central obesity, dyslipidemias, fatty liver disease, hyperinsulinemia, insulin resistance, and hypertension) that affec...
- Bacterial Protein Kinase Inhibitors
[作者:Kurosu, M; Begari, E,期刊:Drug Development Research, 页码:168-187 , 文章类型: Review,,卷期:2010年71-3]
- Protein kinases have become the second most important group of drug targets for the pharmaceutical industry next to G-protein-coupled receptors. Thus, over the past decade, a significant number of small molecules have be...
|